In line with the above, SHH medulloblastoma is characterized by an overall deregulation of SHH signaling that is often accompanied by mutually exclusive mutations in SHH pathway components, underlining the importance of this pathway in driving tumorigenesis (Kool et al., 2014; Northcott et al., 2012a). The gene discussed is SHH; the disease is medulloblastoma.